H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $75.00 price target on Silence Therapeutics (NASDAQ: SLN).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments